Visian ICL The Visian ICL logo
Primary Navigation
  • Acerca de ICL
  • Por qué ICL
  • Centro de ayuda
  • Encuentra Tu Médico
  • Menu
  • Información sobre seguridad
  • es
Close
Buscas algo en concreto?
Acerca de ICL
  • Acerca de ICL
  • Material
  • Requisitos
  • El procedimiento
  • El precio
  • Riesgos
  • Más
Por qué ICL
  • Sin síndrome de ojo seco
  • Procedimiento no invasivo
  • Removible
  • Procedimiento rápidos
  • Protección contra rayos UV
  • Resultados estupendos
  • Las ICL tratan una gran rango de graduaciones
Centro de ayuda
  • Algunas preguntas frecuentes
  • Contacto
Más sobre ICL
  • Miopía e Hipermetropía
  • Cataratas
  • Sobre Glaucoma
  • LASIK
  • PRK
  • Material avanzado de Collamer®
  • Información sobre seguridad
Contacto Información sobre seguridad
  • YouTube
  • Vimeo
Encuentra tu médico Encuentra Tu Médico
Close

Select Your Region

Europe
  • Austria
  • Belgium - Dutch
  • Belgium - French
  • France
  • Germany
  • Italy
  • Netherlands
  • Norway
  • Portugal
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • UK & Ireland
North America
  • Canada
  • Canada - French
  • Mexico
  • United States
Latin America
  • Spanish
  • Portuguese
  • English
North Africa
  • French
  • Arabic
Middle East
  • Middle East عربى
  • Middle East - فارسي
  • Middle East - English
Asia Pacific
  • India
  • Japan - 日本
  • China - 中国
  • S. Korea - 대한민국
  • Australia
  • New Zealand
  • South East Asia
Seleccionar Uno
ICL

ICL is an innovative long term solution for nearsightedness

Learn More

Información sobre seguridad

The ICL is designed for the correction/reduction of myopia in adults ranging from -0.5 D to -20.0 D with or without astigmatism up to 6.0 D and the correction/reduction of hyperopia in adults with hyperopia ranging from +0.5 D to +16.0 D with or without astigmatism up to 6.0 D. It is indicated for patients who are 21 to 45 years of age. In order to be sure that your surgeon will use an ICL with the most adequate power for your eye, your nearsightedness, farsightedness and astigmatism should be stable for at least a year before undergoing eye surgery. ICL surgery may improve your vision without eyeglasses or contact lenses. ICL surgery does not eliminate the need for reading glasses, even if you have never worn them before. ICL represents an alternative to other refractive surgeries including, laser assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), incisional surgeries, or other means to correct your vision such as contact lenses and eye glasses. Implantation of an ICL is a surgical procedure, and as such, carries potentially serious risks. The following represent potential complications/adverse reactions reported in conjunction with refractive surgery in general: additional surgeries, cataract formation, loss of best corrected vision, raised pressure inside the eye, loss of cells on the innermost surface of the cornea, conjunctival irritation, acute corneal swelling, persistent corneal swelling, endophthalmitis (total eye infection), significant glare and/or halos around lights, hyphaema (blood in the eye), hypopyon (pus in the eye), eye infection, ICL dislocation, macular oedema, non-reactive pupil, pupillary block glaucoma, severe inflammation of the eye, iritis, uveitis, vitreous loss and corneal transplant. Before considering ICL surgery you should have a complete eye examination and talk with your eye care professional about ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery.

Note: Indications vary by market. Check with your doctor to determine the indications in your country.


Patient Information (staar.com)

Fuentes:

1 Toda I, Asano-Kato N, Hori-Komai Y, Tsubota K. Laser-Assisted In Situ Keratomileusis for Patients With Dry Eye. Archives of Ophthalmology. 2002;120(8):1024-1028
2 Yu E, Leung A, Rao S, Lam DSC. Effect of laser in situ keratomileusis on tear stability. Ophthalmology, 2000; 107:2131-2135
3 ICL in Treatment of Myopia (ITM) Study Group. United States Food and Drug Administration clinical trial of the Implantable Collamer Lens (ICL) for moderate to high myopia. Ophthalmology. 2004;111:1683-1692

Encuentra Tu Médico
Volver arriba

Secondary Navigation

  • Información sobre seguridad
  • Contacto
  • © 2025 . All rights reserved.
  • Política de privacidad
  • Términos de uso
  • International Sites

Social Navigation

  • YouTube
  • Vimeo
Mantente actualizado sobre Visian ICL